[Failures and prospects for therapy of leukemia].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 4072090)

Published in Vopr Onkol on January 01, 1985

Authors

V N Shabalin, K M Abdulkadyrov

Articles by these authors

(truncated to the top 100)

[The combination of chronic myeloid leukemia and multiple myeloma in one patient]. Vopr Onkol (2013) 0.88

[Cellular composition of hemopoietic tissue of the liver and spleen in the human fetus]. Arkh Anat Gistol Embriol (1984) 0.82

A rapid RT-PCR based method for the detection of BCR-ABL translocation. Mol Pathol (1997) 0.81

HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemia. Ann Hematol (2001) 0.80

[Wilms tumor gene (WT1) expression in blood cells from patients with myelodysplastic syndrome]. Vopr Onkol (2004) 0.77

[Incidence and characteristics of complications in aplastic anemia patients treated with antilymphocytic globulin]. Ter Arkh (2003) 0.77

[Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22)]. Ter Arkh (2014) 0.76

[Hemorrhagic and neurological complications in aplastic anemia patients]. Ter Arkh (1996) 0.76

[Some biochemical characteristics of the leukocytes in chronic reticulosis]. Probl Gematol Pereliv Krovi (1972) 0.75

[Treatment characteristics in chronic myeloleukemia]. Sov Med (1979) 0.75

[Clinical immunological signs, prevention and treatment of a secondary disease]. Sov Med (1980) 0.75

[Rheologic and coagulational disorders and their correction with heparin in patients with autoimmune thrombocytopenic purpura treated with antilymphocytic globulin]. Gematol Transfuziol (1991) 0.75

[Problems of the pathogenesis, diagnosis and treatment of so-called hemopoietic dysplasia]. Gematol Transfuziol (1988) 0.75

[Ultrastructural organization of the hematopoietic microenvironment of human bone marrow]. Gematol Transfuziol (1991) 0.75

[The basic mechanisms of the development of kidney failure and the methods for its correction in multiple myeloma]. Ter Arkh (1992) 0.75

[Differential diagnosis between hypoplastic and aplastic anemias (clinical-morphological parallels)]. Ter Arkh (1968) 0.75

[Results of a cooperative clinical study of a Soviet thioguanine preparation in hemoblastosis]. Probl Gematol Pereliv Krovi (1981) 0.75

[Clinical morphological, cytogenetic and genealogical studies of patients with chronic monocytic leukemia]. Vopr Onkol (1979) 0.75

[Antilymphocyte immunoglobulin with an associated antibacterial directed effect. II. The use of the preparation in the overall therapy of chronic lympholeukemia]. Zh Mikrobiol Epidemiol Immunobiol (1979) 0.75

[The use of autotransfusions of photo-modified blood in the combined treatment of hematology patients]. Ter Arkh (1992) 0.75

[Our experience with the treatment of multiple myeloma and its complications]. Probl Gematol Pereliv Krovi (1979) 0.75

[Stages in the formation of various atypical forms of acute leukemia: hematopoietic dysplasia--preleukemia--leukemia]. Klin Med (Mosk) (1985) 0.75

[Changes in the rheologic properties of erythrocytes in various hematologic diseases]. Gematol Transfuziol (1989) 0.75

[Diagnosis of chronic monocytic leukemia]. Vopr Onkol (1981) 0.75

[Endosteal cells of the bone marrow stroma in human iliac bone]. Arkh Anat Gistol Embriol (1988) 0.75

[Treatment of iron deficiency anemia and the prevention of its recurrences using Soviet iron-containing preparations]. Klin Med (Mosk) (1980) 0.75

[Method of obtaining hemopoietic cells from fetal organs and their morphofunctional characteristics]. Probl Gematol Pereliv Krovi (1982) 0.75

[Comparative study of 2 preparations of cyclocytidine (USSR, Japan) in leukemia patients]. Probl Gematol Pereliv Krovi (1982) 0.75

[2 cases of acute leukemia with eosinophilic reaction]. Probl Gematol Pereliv Krovi (1978) 0.75

[Results of treatment of iron-deficiency anemia by intramuscular administration of ferbitol]. Ter Arkh (1968) 0.75

[Use of thymalin in a patient with immunologic deficiency state after thymectomy]. Klin Med (Mosk) (1983) 0.75

[Current problems of the treatment of leukemia]. Gematol Transfuziol (1983) 0.75

[Immunological and rheological disorders in multiple myeloma patients]. Ter Arkh (1991) 0.75

[The polychemotherapy of patients with multiple myeloma]. Vopr Onkol (1992) 0.75

[Kidney involvement in multiple myeloma]. Vrach Delo (1990) 0.75

[Lipid-bound sialic acids and DNA-binding proteins of the blood serum in diseases of the blood system]. Lab Delo (1988) 0.75

[Early and late results of splenectomy in Werlhof's disease]. Probl Gematol Pereliv Krovi (1966) 0.75

[Polychemotherapy, hemosorption and blastapheresis in the treatment of patients with acute leukemia]. Gematol Transfuziol (1985) 0.75

[Treatment of chronic lympholeukemia patients as outpatients]. Gematol Transfuziol (1985) 0.75

[The necessity for the combined use of the ultrasonic study of the abdominal cavity organs and of the histomorphometry of the bone marrow in chronic myeloleukemia]. Ter Arkh (1993) 0.75

[The prognostic role of determining spontaneous leukocyte DNA damage and that occurring during chemotherapy in leukemia patients]. Vestn Ross Akad Med Nauk (1993) 0.75

[Case of immunoblastic lymphadenopathy]. Klin Med (Mosk) (1981) 0.75

[Chronic eosinophilic myeloleukemia]. Vrach Delo (1983) 0.75

[Acetylcholinesterase of erythrocytes in various blood diseases]. Vopr Med Khim (1977) 0.75

[The hemostatic system of hypoplastic anemia patients during treatment with antilymphocyte immunoglobulin]. Gematol Transfuziol (1987) 0.75

[Blood component and infusion-detoxification therapy of patients with hematologic diseases]. Gematol Transfuziol (1984) 0.75

[Heart involvement in patients with multiple myeloma based on echocardiographic data]. Vrach Delo (1991) 0.75

[Rheologic properties of the erythrocytes and hemostatic system in patients with polycythemia vera]. Gematol Transfuziol (1989) 0.75

[Erythrocyte enzymes in functional hyperbilirubinemia]. Klin Med (Mosk) (1977) 0.75

[Changes in the concentration of 2,3-diphosphoglycerate and adenosine triphosphate in the erythrocytes of leukemia patients]. Probl Gematol Pereliv Krovi (1976) 0.75

[Use of ultrahigh frequency electromagnetic irradiation in the treatment of infectious complications in patients with hemoblastoses]. Gematol Transfuziol (1991) 0.75

[Basic principles of the ambulatory care of patients with leukemia]. Gematol Transfuziol (1983) 0.75

[Ultrasonography in hematological practice]. Gematol Transfuziol (1989) 0.75

[Comparative evaluation of the effectiveness of mono- and polychemotherapy programs in patients with multiple myeloma]. Klin Med (Mosk) (1993) 0.75

[Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease]. Klin Med (Mosk) (1991) 0.75

[Use of plasmapheresis in surgical hematology]. Vestn Khir Im I I Grek (1983) 0.75

[Treatment of hypoplastic anemia with bone marrow transplants and use of antilymphocyte globulin]. Vestn Akad Med Nauk SSSR (1973) 0.75

[Hemosorption combined with intensive measures in hemoblastoses]. Vopr Onkol (1985) 0.75

[Structure of the bone marrow stroma and hematopoiesis following chemotherapy in patients with acute myeloblastic leukemia]. Ter Arkh (1986) 0.75

[Histomorphometry of structures of hematopoietic microenvironment of the iliac bone marrow]. Gematol Transfuziol (1985) 0.75

[Main achievements and perspectives of development of hematology and transfusiology in the USSR]. Probl Gematol Pereliv Krovi (1977) 0.75

[Cytomorphological and biochemical characteristics of the blast cells in acute promyelocytic leukemia]. Probl Gematol Pereliv Krovi (1978) 0.75

[Immunological and rheological parallels in patients with autoimmune thrombocytopenic purpura treated with antilymphocyte globulin]. Klin Med (Mosk) (1990) 0.75

[Rheologic properties of erythrocytes of the hemostatic system in patients with acute lymphoblastic leukemia]. Gematol Transfuziol (1991) 0.75

[Changes in the functional status of the myocardium in acute leukemia patients]. Vrach Delo (1991) 0.75

[Transplantation of embryonic hematopoietic and lymphoid organs and cells in the treatment of hematologic diseases]. Gematol Transfuziol (1983) 0.75

[Rheological properties of erythrocytes and hemostasis in patients with acquired autoimmune hemolytic anemia treated with anti- lymphocyte globulin]. Gematol Transfuziol (1990) 0.75

[Immunological support of component blood transfusion therapy]. Probl Gematol Pereliv Krovi (1978) 0.75

[Transplantation of autologous bone marrow in the treatment of acute leukemia]. Klin Med (Mosk) (1986) 0.75

[Changes in the blood coagulation system in patients with hypo- and aplastic anemia]. Probl Gematol Pereliv Krovi (1966) 0.75

[Histotopographic interrelations of stromal structures and hematopoietic cells of human bone marrow]. Gematol Transfuziol (1987) 0.75

[Concerning the article by Prof. A.I. Vorob'ev and M.D. Brilliant "Problem of criteria in the classification of leukemias"]. Probl Gematol Pereliv Krovi (1974) 0.75

[Echocardiographic indicators in chronic lymphocytic leukemia]. Sov Med (1990) 0.75

[Methods of influencing immunity in leukemia]. Gematol Transfuziol (1984) 0.75

[Correction of disorders in the rheological properties of the blood in polycythemia vera patients using polidez]. Gematol Transfuziol (1986) 0.75

[Ultrasonography of the gallbladder in patients with hemoblastoses]. Klin Med (Mosk) (1992) 0.75

[Use of antilymphocytic immunoglobulin after bone marrow transplantation]. Probl Gematol Pereliv Krovi (1978) 0.75

[The importance of sonography in the diagnosis of extramedullary hematopoietic foci in acute leukemia]. Vopr Onkol (1991) 0.75

[Some data on the activity of adenosine triphosphatase and acetylcholinesterase in the erythrocytes of patients with various forms of anemia]. Probl Gematol Pereliv Krovi (1975) 0.75

[Surgical treatment methods in blood diseases]. Vestn Khir Im I I Grek (1982) 0.75

[Blood coagulation and the role of erythrocytes in the process of hemostasis in hypoplastic anemia]. Probl Gematol Pereliv Krovi (1971) 0.75

[Use of defrosted erythrocytes in hematologic diseases]. Probl Gematol Pereliv Krovi (1977) 0.75

[Parenteral feeding of patients with leukemia]. Gematol Transfuziol (1986) 0.75

[Rheologic and immunologic blood parameters in patients with hypoplastic anemia who received antilymphocytic globulin]. Gematol Transfuziol (1991) 0.75

[Rheologic and hemocoagulation parameters in patients with multiple myeloma during therapy]. Gematol Transfuziol (1992) 0.75

[Ultrasonographic examination of the liver and abdominal lymph nodes in patients with chronic lymphocytic leukemia]. Gematol Transfuziol (1991) 0.75

[Diagnosis of idiopathic myelofibrosis]. Sov Med (1983) 0.75

[Modern concepts of the pathogenesis of anemia in chronic myeloid and lymphatic leukemias (a review of the literature and the authors' own data)]. Probl Gematol Pereliv Krovi (1972) 0.75

[The diagnostic importance of echography of the spleen, abdominal lymph nodes and vessels in chronic lympho- and myeloleukemias]. Ter Arkh (1990) 0.75

[Use of typing anti-leukocyte sera for selection of bone marrow donors]. Probl Gematol Pereliv Krovi (1971) 0.75

[Clinico-morphological characteristics of chronic lympholeukemia]. Gematol Transfuziol (1988) 0.75

[Cytochemical characteristics of bone marrow reticular cells in healthy people and in patients with various forms of leukoses-reticuloses]. Probl Gematol Pereliv Krovi (1971) 0.75

[Circulatory failure and the methods for its correction in multiple myeloma]. Ter Arkh (1992) 0.75

[Adipocytes and reticular cells of the bone marrow stroma in the human iliac bone]. Arkh Anat Gistol Embriol (1987) 0.75

[Enhanced osteogenesis in severe aplastic anemia]. Gematol Transfuziol (1993) 0.75

[Treatment of chronic monocytic leukemia]. Vopr Onkol (1982) 0.75

[Sinusoids of the bone marrow stroma in the human iliac bone]. Arkh Anat Gistol Embriol (1987) 0.75

[Characteristics of hematopoiesis in patients with chronic leukosis-reticulosis]. Probl Gematol Pereliv Krovi (1970) 0.75

[Leukocyte glycosaminoglycans in various forms of myelo- and lymphoproliferative blood diseases]. Vopr Onkol (1986) 0.75

[The effect of different programs of cytostatic therapy on the blood coagulation and rheological properties in multiple myeloma patients]. Ter Arkh (1991) 0.75